Vaxcyte Inc (PCVX)

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	12.45%302.78	345.85	274.28	242.38	226.22
Research and Development	14.36%267.85	312.78	242.06	209.93	194.18
Operating Income/Loss	12.45%-302.78	-345.85	-274.28	-242.38	-226.22
Nonoperating Income/Loss	26.77%18.48	25.23	27.78	29.55	59.65
Income Tax Expense/Benefit	-	-	-	-	-
	11.33%-284.30	-320.62	-246.51	-212.83	-166.57
Attributable To Parent	11.33%-284.30	-320.62	-246.51	-212.83	-166.57
Available To Common Stockholders, Basic	11.33%-284.30	-320.62	-246.51	-212.83	-166.57
Basic Average Shares	3.58%144.49	139.51	-	136.20	136.03
Diluted Average Shares	3.58%144.49	139.51	-	136.20	136.03
Basic Earnings Per Share	14.35%-1.97	-2.30	-	-1.56	-1.22
Diluted Earnings Per Share	14.35%-1.97	-2.30	-	-1.56	-1.22